MUPIROCIN RESISTANCE AMONG CONSECUTIVE ISOLATES OF OXACILLIN-RESISTANT AND BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS AT A UNIVERSITY HOSPITAL

被引:37
|
作者
LAYTON, MC
PATTERSON, JE
机构
[1] YALE UNIV,SCH MED,DEPT MED,INFECT DIS SECT,NEW HAVEN,CT 06520
[2] YALE UNIV,SCH MED,DEPT LAB MED,NEW HAVEN,CT 06520
关键词
D O I
10.1128/AAC.38.7.1664
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mupirocin resistance was determined in consecutive oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus clinical isolates collected over 14 months at a university hospital during 1991 and 1992. Twenty of 86 (23%) oxacillin-resistant and borderline oxacillin-resistant S. aureus isolates were mupirocin resistant; 80% were high-level resistant. Prior mupirocin use was a significant risk factor (relative risk, 6.08; 95% confidence interval, 3.7 to 9.99). Seven of 20 resistant isolates were distinct strains, as determined by pulsed-field gel electrophoresis typing. Two instances of clonal dissemination of a single strain occurred, but several other distinct mupirocin-resistant strains were documented. Mupirocin resistance was unexpectedly common among these isolates.
引用
收藏
页码:1664 / 1667
页数:4
相关论文
共 50 条
  • [1] HIGH-RATE OF OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ISOLATES IN AN ITALIAN UNIVERSITY HOSPITAL
    VENDITTI, M
    BAIOCCHI, P
    BRANDIMARTE, C
    CAPONE, A
    FIMIANI, C
    SANTINI, C
    TARASI, A
    [J]. JOURNAL OF CHEMOTHERAPY, 1994, 6 (01) : 25 - 28
  • [2] PHAGE PATTERN-SPECIFIC OXACILLIN-RESISTANT AND BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN UNITED-STATES HOSPITALS - EPIDEMIOLOGIC SIGNIFICANCE
    ZIERDT, CH
    HOSEIN, IK
    SHIVELY, R
    MACLOWRY, JD
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (01) : 252 - 254
  • [3] A class A β-lactamase produced by borderline oxacillin-resistant Staphylococcus aureus hydrolyses oxacillin
    Nomura, Ryo
    Nakaminami, Hidemasa
    Takasao, Kotaro
    Muramatsu, Shuna
    Kato, Yuji
    Wajima, Takeaki
    Noguchi, Norihisa
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 244 - 247
  • [4] Oxacillin-resistant phenotypes of Staphylococcus aureus
    Haberberger, RL
    Kallen, AJ
    Driscoll, TJ
    Wallace, MR
    [J]. LABORATORY MEDICINE, 1998, 29 (05) : 302 - 305
  • [5] VANCOMYCIN THERAPY OF OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS
    KLASTERSKY, J
    COPPENS, L
    VANDERAUWERA, P
    MEUNIERCARPENTIER, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (04) : 361 - 367
  • [6] Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus
    Croes, S.
    Beisser, P. S.
    Terporten, P. H.
    Neef, C.
    Deurenberg, R. H.
    Stobberingh, E. E.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (07) : 979 - 985
  • [7] BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN CHILDREN WITH CYSTIC FIBROSIS
    Blanchard, A.
    Yau, Y.
    Shaw, M.
    Waters, V. J.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 : S158 - S158
  • [8] CHARACTERIZATION OF RESISTANCE PHENOTYPE AND CEPHALOSPORIN ACTIVITY IN OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    MATEOSMORA, M
    KNAPP, CC
    WASHINGTON, JA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) : 170 - 174
  • [9] DETECTION OF BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS AND DIFFERENTIATION FROM METHICILLIN-RESISTANT STRAINS
    LIU, H
    BUESCHER, G
    LEWIS, N
    SNYDER, S
    JUNGKIND, D
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (10) : 717 - 724
  • [10] Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus
    Climo, MW
    Ehlert, K
    Archer, GL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) : 1431 - 1437